Citigroup’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $27 | Sell |
|
|||||
|
2024
Q3 | $65 | Sell |
|
|||||
|
2024
Q2 | $27K | Buy |
|
|||||
|
2024
Q1 | $13K | Buy |
|
|||||
|
2023
Q4 | $7.18K | Sell |
|
|||||
|
2023
Q3 | $671K | Sell |
|
|||||
|
2023
Q2 | $776K | Sell |
|
|||||
|
2023
Q1 | $2.64M | Sell |
|
|||||
|
2022
Q4 | $3.36M | Sell |
|
|||||
|
2022
Q3 | $4.88M | Buy |
|
|||||
|
2022
Q2 | $8.05M | Buy |
|
|||||
|
2022
Q1 | $8.04M | Sell |
|
|||||
|
2021
Q4 | $16M | Buy |
|
|||||
|
2021
Q3 | $4.85M | Sell |
|
|||||
|
2021
Q2 | $6.68M | Buy |
|
|||||
|
2021
Q1 | $6.15M | Sell |
|
|||||
|
2020
Q4 | $24.8M | Buy |
|
|||||
|
2020
Q3 | $2.27M | Sell |
|
|||||
|
2020
Q2 | $3.28M | Buy |
|
|||||
|
2020
Q1 | $1.83M | Buy |
|
|||||
|
2019
Q4 | $3M | Buy |
|
|||||
|
2019
Q3 | $2.14M | Buy |
|
|||||
|
2019
Q2 | $1.39M | Buy |
|
|||||
|
2019
Q1 | $602K | Sell |
|
|||||
|
2018
Q4 | $3.9M | Buy |
|
|||||
|
2018
Q3 | $3.46M | Buy |
|
|||||
|
2018
Q2 | $2.04M | Sell |
|
|||||
|
2018
Q1 | $2.32M | Buy |
|
|||||
|
2017
Q4 | $4K | Buy |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $2K | Sell |
|
|||||
|
2017
Q1 | $5K | Sell |
|
|||||
|
2016
Q4 | $627K | Buy |
|
|||||
|
2016
Q3 | $47K | Sell |
|
|||||
|
2016
Q2 | $135K | Sell |
|
|||||
|
2016
Q1 | $228K | Buy |
|
|||||
|
2015
Q4 | $42K | Sell |
|
|||||
|
2015
Q3 | $496K | Buy |
|
|||||
|
2015
Q2 | $14K | Sell |
|
|||||
|
2015
Q1 | $1.09M | Buy |
|
|||||
|
2014
Q4 | $26K | Buy |
|